109182
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
Tnfrsf1b 能保护斑马鱼免受肺炎克雷伯菌感染
Authors Jing Y, Xu Z, Ju F, Wang M, Tu F, Rui X, Cao F, Liu J
Received 29 May 2025
Accepted for publication 17 October 2025
Published 25 October 2025 Volume 2025:18 Pages 5473—5488
DOI https://doi.org/10.2147/IDR.S535974
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Hazrat Bilal
Yanfei Jing,1,* Ze Xu,2,* Feng Ju,3,* Mingyong Wang,4 Fan Tu,5 Xiaohong Rui,5 Futao Cao,6 Jun Liu5
1Department of Function, Affiliated Wuxi Fifth Hospital of Jiangnan University, Wuxi, 214005, People’s Republic of China; 2Department of Laboratory Medicine, The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi, 214023, People’s Republic of China; 3Department of Digestive, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China; 4Murui Biological Technology Co., Ltd., Suzhou Industrial Park, Suzhou, People’s Republic of China; 5Department of Laboratory Medicine, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China; 6Department of Emergency, Jiangnan University Medical Center, Wuxi, 214005, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jun Liu, Department of Laboratory Medicine, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China, Email liujun910628@126.com Futao Cao, Department of Emergency, Jiangnan University Medical Center, Wuxi, 214005, People’s Republic of China, Email caofutao999@163.com
Objective: Klebsiella (K). pneumoniae is an opportunistic pathogen that causes severe infections in the lungs, urinary tract, and liver, yet its pathogenesis remains unclear. Tnfrsf1b, a member of the tumor necrosis factor receptor superfamily, is associated with inflammation and tissue damage. The objective of this study was to investigate the functional role of tnfrsf1b in zebrafish during K. pneumoniae infection and tnfrsf1b should be considered a candidate target for further investigation.
Methods: A tnfrsf1b-knockout zebrafish line was generated using CRISPR/Cas9 technology. Both wild-type and mutant zebrafish were infected with the hypervirulent K. pneumoniae strain NTUH-K2044. Phenotypic changes, immune cell recruitment, and cytokine production were assessed using Alcian blue staining, Sudan Black B staining, neutral red staining, qRT-PCR, and ELISA. Rescue experiments were performed by injecting capped tnfrsf1b mRNA into mutants and wild-type zebrafish embryos. Pharmacological inhibition was tested using the TNFR inhibitor R7050.
Results: Compared with wild-type zebrafish, tnfrsf1b-knockout mutants exhibited significantly higher malformation and mortality rates, increased recruitment of macrophages and neutrophils, and elevated levels of pro-inflammatory cytokines (TNF-α, IL-1β). Similar phenotypes were observed in R7050-treated zebrafish. K. pneumoniae infection further exacerbated these immune dysfunctions in tnfrsf1b mutants. Injection of capped tnfrsf1b mRNA into mutants partially rescued developmental and immune defects, while overexpression in wild-type zebrafish conferred protection against K. pneumoniae-induced damage.
Conclusion: tnfrsf1b plays a critical role in regulating host immune responses and protecting zebrafish from K. pneumoniae infection. Targeting the tnfrsf1b signaling pathway may represent a promising therapeutic approach for managing infections caused by hypervirulent K. pneumoniae.
Keywords: tnfrsf1b, Klebsiella pneumoniae, zebrafish, inflammation, infection susceptibility
1Department of Function, Affiliated Wuxi Fifth Hospital of Jiangnan University, Wuxi, 214005, People’s Republic of China; 2Department of Laboratory Medicine, The Affiliated Wuxi Center for Disease Control and Prevention of Nanjing Medical University, Wuxi, 214023, People’s Republic of China; 3Department of Digestive, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China; 4Murui Biological Technology Co., Ltd., Suzhou Industrial Park, Suzhou, People’s Republic of China; 5Department of Laboratory Medicine, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China; 6Department of Emergency, Jiangnan University Medical Center, Wuxi, 214005, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Jun Liu, Department of Laboratory Medicine, Wuxi Fifth People’s Hospital Affiliated Jiangnan University, Wuxi, 214005, People’s Republic of China, Email liujun910628@126.com Futao Cao, Department of Emergency, Jiangnan University Medical Center, Wuxi, 214005, People’s Republic of China, Email caofutao999@163.com
Objective: Klebsiella (K). pneumoniae is an opportunistic pathogen that causes severe infections in the lungs, urinary tract, and liver, yet its pathogenesis remains unclear. Tnfrsf1b, a member of the tumor necrosis factor receptor superfamily, is associated with inflammation and tissue damage. The objective of this study was to investigate the functional role of tnfrsf1b in zebrafish during K. pneumoniae infection and tnfrsf1b should be considered a candidate target for further investigation.
Methods: A tnfrsf1b-knockout zebrafish line was generated using CRISPR/Cas9 technology. Both wild-type and mutant zebrafish were infected with the hypervirulent K. pneumoniae strain NTUH-K2044. Phenotypic changes, immune cell recruitment, and cytokine production were assessed using Alcian blue staining, Sudan Black B staining, neutral red staining, qRT-PCR, and ELISA. Rescue experiments were performed by injecting capped tnfrsf1b mRNA into mutants and wild-type zebrafish embryos. Pharmacological inhibition was tested using the TNFR inhibitor R7050.
Results: Compared with wild-type zebrafish, tnfrsf1b-knockout mutants exhibited significantly higher malformation and mortality rates, increased recruitment of macrophages and neutrophils, and elevated levels of pro-inflammatory cytokines (TNF-α, IL-1β). Similar phenotypes were observed in R7050-treated zebrafish. K. pneumoniae infection further exacerbated these immune dysfunctions in tnfrsf1b mutants. Injection of capped tnfrsf1b mRNA into mutants partially rescued developmental and immune defects, while overexpression in wild-type zebrafish conferred protection against K. pneumoniae-induced damage.
Conclusion: tnfrsf1b plays a critical role in regulating host immune responses and protecting zebrafish from K. pneumoniae infection. Targeting the tnfrsf1b signaling pathway may represent a promising therapeutic approach for managing infections caused by hypervirulent K. pneumoniae.
Keywords: tnfrsf1b, Klebsiella pneumoniae, zebrafish, inflammation, infection susceptibility